Rua Bioscience is trading at $0.04, up 11.11%, although no clear company-specific announcement dated September 5–7, 2026, was identified.
- Its latest material update reported 71% customer-revenue growth to $2.58 million and $2.3 million of new shareholder capital on August 28.
- September 7 is the director-nomination deadline, but no source directly links it to the move.
- Major indices were essentially flat, offering no clear broader-market explanation.